Cancer-control outcomes of Radium- 223-pretreated lutetium- 177-PSMA Radioligand vs. Radium- 223-naïve mCRPC patients. - Wenzel M; Theissen L; Groener D; Kriegmair M; Graefen M; Maurer T; Salomon G; Hoeh B; Siech C; Banek S; Chun FKH; Mandel P (European journal of nuclear medicine and molecular imaging, 2025)